Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...

Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to ...

Within Novo Nordisk's comprehensive business update ... extend and sustain the obesity franchise as new competitors like Eli Lilly, Pfizer, MSD, and Boehringer Ingelheim/Zealand Pharma start ...

Novo Nordisk has doubled down on position in the sickle cell disease (SCD) category with a $1.1 billion agreement to acquire Forma Therapeutics, and its therapeutic candidate etavopivat ...